Atlas Trials

AMG 319 Lymphoid Malignancy FIH

Clinical trial NCT01300026 · COMPLETED

Trial details

NCT number
NCT01300026
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
CancerChronic Lymphocytic LeukemiaDiffuse Large Cell LymphomaHematologic MalignanciesHematologyLeukemiaLow Grade LymphomaLymphomaMantle Cell LymphomaNon-Hodgkin's LymphomaOncologyOncology Patients
Start date
2011-04-01
Primary completion
2013-10-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.